How can a physician practice build a Physician Practice Compliance Program that is practical and responsive to its risks? This guide shows how to combine OIG guidance, risk assessment, and scalable implementation. It presents the broader topic of medical practice compliance programs for physician practices. It also distinguishes recommended practices from applicable legal obligations.
Executive Summary
John H. Fisher | Health Care Lawyer for Physicians and other Health Care Providers
A Physician Practice Compliance Program works best when it is risk-focused and scalable—not off-the-shelf policy manuals. For physician practices, use OIG guidance as a framework, distinguish its voluntary recommendations from applicable legal obligations, and translate documented risk priorities into action across all seven recommended elements.
A Physician Practice Compliance Program works best when it is risk-focused and scalable—not off-the-shelf policy manuals. For physician practices, use OIG guidance as a framework, distinguish its voluntary recommendations from applicable legal obligations, and translate documented risk priorities into action across all seven recommended elements.
Identify and prioritize compliance risks. Assess the practice’s full risk universe, including the coding and billing, medical necessity, documentation, and referral-related risks discussed in this article.
Scale your physician practice compliance program. Match staffing, policies, training, oversight, and auditing to the practice’s operations, assessed risks, and available resources. Simpler implementation does not make legal obligations optional.
Document decisions and test effectiveness. Record the rationale for priorities and resource choices, assign responsibility, and identify review timing and supporting evidence.
Keep the compliance risk assessment current. Use staff reports, audit findings, and corrective-action results to reassess risks, adjust controls, and document changes.
Keep Your Medical Practice Compliance Program Practical
Every physician practice should have a compliance program, but it need not be lengthy or complicated. Practical physician practice compliance programs fit the practice’s needs and available resources.
Focus on the issues relevant to your practice and the steps you can realistically carry out. Tailor off-the-shelf policies before adopting them; otherwise, you may create commitments your practice cannot fulfill.
Core Elements of Medical Practice Compliance Programs
A Physician Practice Compliance Program should:
Address the seven elements OIG recommends for an effective compliance program.
Describe the steps your practice will take to meet each element.
Include a basic code of conduct that reflects your commitment to a culture of compliance.
OIG Guidance for Physician Practice Compliance Programs
The Office of Inspector General (OIG) published its Compliance Program Guidance for Individual and Small Group Physician Practices in the Federal Register on October 5, 2000 (65 FR 59434–59452). Review this physician-specific guidance alongside OIG’s General Compliance Program Guidance, published on November 6, 2023, particularly its discussion of adaptations for small entities. Both documents provide voluntary, nonbinding guidance to help practices develop compliance programs suited to their needs and resources.
Recommendations Versus Legal Obligations
OIG’s General Compliance Program Guidance is voluntary and nonbinding. Its use of “should” expresses a recommendation, not a new legal requirement. Practices should distinguish this guidance from their obligations under applicable laws and Federal health care program requirements. The guidance discusses authorities such as the Anti-Kickback Statute, physician self-referral law (Stark Law), False Claims Act, and HIPAA; following a compliance framework is not a substitute for complying with those applicable obligations.
Adapt Your Compliance Program to the Practice
The 2000 physician-specific guidance emphasizes a flexible, step-by-step approach reflecting staffing and financial constraints. The 2023 general guidance recommends encompassing all seven elements while adapting implementation to a small entity’s needs and resources. These approaches support a practical program rather than an unnecessarily elaborate policy manual.
Under the small-entity adaptations in the 2023 guidance, a practice that cannot support a compliance officer should consider designating a compliance contact. Policies and training should reflect actual operations and risks, rather than relying on unmodified templates. An open-door reporting process may be appropriate instead of a formal disclosure program, but personnel should understand how concerns are investigated and resolved and that good-faith reporting is protected from retaliation.
The physician-specific guidance highlights coding and billing, medical necessity, documentation, and improper inducements, kickbacks, and self-referrals as key risk areas. Use these areas as a starting point, then tailor compliance activities to the risks present in your practice.
Size Matters: Identify Your Practice’s Risk Universe
Risk assessment gives medical practice compliance programs their practical focus. Identify the full range of risks relevant to your practice’s size and scope rather than treating a generic checklist as a complete assessment. Prioritize those risks and direct available compliance resources to the areas that warrant the most attention.
Scale the implementation, not the commitment to compliance. For physician practice compliance programs, scalability means adapting structure and resources to the practice’s size, operations, and identified risks. OIG’s small-entity guidance recommends retaining all seven elements while using arrangements suited to available resources, such as a designated compliance contact and accessible reporting methods. A smaller practice may use simpler processes, but scalability does not make applicable legal obligations optional.
Let risk assessment guide the scale. Use the assessment to decide where more detailed policies, focused training, additional oversight, or more intensive auditing and monitoring are warranted. Headcount alone should not determine those choices: the relevant question is whether the approach addresses the risks identified in your practice. For example, a small practice with recurring billing problems might devote more attention to billing review than its size alone would suggest. This is an illustrative implementation choice, not an OIG-prescribed formula. As operations or findings change, revisit whether the program’s resources and controls remain appropriate.
Medical practice compliance programs need a clear record of the risk assessment process, not just its conclusions. Record how risks were identified, the information considered, how priorities were established, and why resources were directed to particular areas. Include the resulting scalability decisions—such as the level of compliance staffing, the detail of policies, the focus of training, and the scope of auditing and monitoring—and explain how each choice fits the practice’s size, operations, identified risks, and available resources. For each decision, record who is responsible, when effectiveness will be reviewed, and what evidence will be used to judge whether the approach is working, such as audit findings, reported concerns, or the results of corrective measures. Document the review findings and any changes they prompt. This creates a clear record of both the reasoning behind your compliance priorities and how you evaluate the adequacy of the resources and controls selected.
Keep the assessment current through a feedback loop. Staff reports identify concerns, and audits test whether controls are working. Investigate detected problems and use corrective action to address their causes. Feed those findings and the results of corrective measures back into the risk assessment, adjusting compliance priorities, policies, training, and resources as needed. Document what changed and why, then use subsequent reporting and monitoring to check whether the changes are effective.
The Seven Recommended Elements
OIG’s 2023 guidance recommends that leadership commit to all seven elements of an effective physician practice compliance program. Apply the documented priorities and scalability decisions described in “Size Matters: Identify Your Practice’s Risk Universe” through the following elements:
Written policies and procedures: Establish a code of conduct and practice-specific policies, giving priority to procedures that address the identified risks warranting the most attention. Tailor any generic manual before adopting it.
Compliance leadership and oversight: Assign responsibility for compliance and provide leadership support and oversight. Translate assessed priorities into the responsible person’s work; document resource-allocation decisions as described above.
Training and education: Teach personnel how the compliance program applies to their duties and associated risks, focusing training resources on assessed priorities.
Effective lines of communication: Provide accessible ways to raise concerns and protect good-faith reporting from retaliation. Include reported concerns in the reassessment process described above.
Enforcing standards: Apply consequences consistently and use incentives to reinforce compliant conduct. Enforce the standards addressing identified risks regardless of their priority ranking.
Risk assessment, auditing, and monitoring: Maintain the documented assessment of the practice’s full risk universe described above. Focus audits and monitoring on priority areas, using findings to test controls and inform reassessment.
Response and corrective action: Investigate detected problems, address their causes, and implement corrective measures. Feed the lessons into reassessment and updates to policies, training, and resources. A lower priority ranking does not justify leaving a detected problem unaddressed.
July 2026 | Health Care Regulatory and Compliance Update
This health care compliance alert covers key legal and regulatory issues for physician practices and related providers. It highlights Stark Law, Anti-Kickback considerations and related risk areas across platforms. It is relevant for physician practices, medical groups, MSOs, telehealth providers, and ambulatory care settings.
Additionally, the alert discusses physician compensation, fair market value analysis, and corporate practice of medicine restrictions. It also covers MSO compliance, fee-splitting rules, scope-of-practice rules, supervision, and telehealth-related requirements. This guidance also emphasizes Medicare and Medicaid billing accuracy, medical necessity documentation, and audit readiness.
Related compliance topics: physician self-referral law, value-based care arrangements, in-office ancillary services, laboratory compliance, imaging center compliance, physical therapy billing, durable medical equipment compliance, behavioral health telehealth, digital health compliance, professional corporation governance, medical director agreements, independent contractor provider agreements, referral source arrangements, overpayment refunds, claims audit response, health care transaction diligence, and multi-state provider compliance.
Federal and state health care regulators continue to scrutinize the financial, operational, and ownership arrangements that underpin physician practices, management services organizations, telehealth platforms, digital health businesses, and ancillary service lines. Recent developments in health care fraud and abuse enforcement underscore that technically compliant documentation is not always enough: regulators are increasingly focused on intent, operational control, fair market value, clinical independence, medical necessity, billing accuracy, and the practical realities of how arrangements function.
Moreover, Stark Law, Anti-Kickback concerns can arise even when documentation is technically compliant, as regulators evaluate compensation terms, referrals, and potential conflicts of interest that could influence clinical decisions. They increasingly scrutinize how arrangements are implemented in practice, including how ownership interests, governance, and oversight affect patient access, quality, and billing outcomes. This trend underscores the importance of transparent, fair, and value-based structures.
This health care regulatory Alert identifies key compliance themes affecting medical practices, physician groups, MSOs, telehealth companies, remote care platforms, and ancillary service providers, and outlines practical steps organizations should consider to reduce Stark Law, Anti-Kickback Statute, corporate practice of medicine, reimbursement, and billing compliance risk.
Executive Summary: Key Health Care Compliance Risks for Medical Practices and MSOs
Stark Law compliance does not eliminate Anti-Kickback Statute risk. Recent OIG guidance reiterates that an arrangement may satisfy a Stark Law exception yet still present AKS risk depending on the parties’ intent and the totality of the circumstances.
Fair market value remains important but is not a standalone AKS defense. Compensation that is commercially reasonable and consistent with fair market value should still be evaluated for referral-related intent, volume or value concerns, and safe harbor compliance.
State corporate practice of medicine rules are becoming more consequential. Regulators are looking beyond written agreements to determine whether MSOs or other non-clinical entities exercise de facto control over clinical decision-making, physician ownership, staffing, or patient care protocols.
Telehealth and ancillary service arrangements require integrated compliance review. Licensure, supervision, billing, privacy, documentation, and payer requirements should be addressed together rather than managed in separate silos.
Health care organizations should refresh compliance controls now. Contract review, audit protocols, state-specific CPOM analyses, billing controls, and board-level oversight can help reduce risk before regulators, payers, or transaction counterparties identify deficiencies.
Background: Health Care Regulatory Compliance, Physician Practice Management, and Fraud and Abuse Risk
Medical practice structures have become more complex as physician groups, MSOs, telehealth companies, private equity-backed health care platforms, specialty practices, ambulatory care providers, and ancillary service providers pursue growth, integration, consolidation, and new care delivery models. At the same time, federal fraud and abuse enforcement, state corporate practice restrictions, payer audits, revenue cycle reviews, and health care transaction diligence are converging around a common question: whether business arrangements preserve compliant referral relationships, clinical independence, accurate billing, medical necessity, and patient-centered decision-making.
For organizations operating across multiple states or service lines, the compliance analysis is increasingly fact-specific. A form agreement may not be sufficient if day-to-day operations suggest that a non-clinical entity controls clinical judgment, compensation incentives reward referrals, ancillary services lack adequate documentation, or telehealth workflows do not align with licensure and payer requirements.
1. Stark Law, Anti-Kickback Statute, Physician Compensation, and Referral Source Arrangements
Separate Stark Law and AKS Analyses
Recent OIG updates reinforce a point that remains central to health care contracting: Stark Law compliance and AKS compliance are related but distinct analyses. The Stark Law generally operates as a strict liability statute focused on physician financial relationships involving designated health services, while the AKS is an intent-based statute that prohibits knowingly and willfully offering, paying, soliciting, or receiving remuneration to induce or reward referrals of federal health care program business.
Accordingly, satisfying a Stark Law exception does not, standing alone, insulate an arrangement from AKS scrutiny. Similarly, compensation that is consistent with fair market value may be a critical compliance factor, but it is not a standalone AKS safe harbor. Regulators may still examine whether one purpose of the arrangement was to induce or reward referrals, whether the compensation methodology is commercially reasonable, and whether the parties documented the legitimate business rationale for the arrangement.
What this means for providers: Physician employment agreements, independent contractor provider agreements, medical director agreements, value-based care incentives, shared savings models, call coverage agreements, marketing arrangements, space and equipment leases, referral source arrangements, and ancillary service relationships should be reviewed for both Stark Law and AKS purposes. Organizations should document fair market value, commercial reasonableness, legitimate service need, safe harbor or exception analysis, and the absence of referral-based intent, and should implement periodic monitoring to confirm that arrangements operate as written.
2. Scope-of-Practice Compliance, Supervision Requirements, Credentialing, and Provider Billing Rules
State Scope-of-Practice Rules for Non-Physician Providers
States continue to expand, narrow, or clarify the scope of practice for nurse practitioners, physician assistants, pharmacists, behavioral health providers, and other non-physician practitioners. These changes can create opportunities to expand access to care, but they also introduce compliance risk if supervision, delegation, credentialing, billing, and documentation practices do not keep pace.
Organizations should maintain state-specific protocols addressing who may perform particular services, what level of physician collaboration or supervision is required, how services are documented, and how services are billed. Payer rules may impose additional requirements beyond state licensure laws, particularly for incident-to billing, split/shared services, telehealth, remote patient monitoring, and ancillary services.
Supervision, Delegation, Credentialing, and Billing Risk Areas
Risk areas to monitor: inconsistent collaborative agreements, outdated supervision policies, provider services performed outside permitted scope, billing under the wrong provider, insufficient chart review, unclear escalation pathways, and onboarding materials that do not reflect current state law.
Recommended action: Practices should conduct periodic state-by-state reviews of provider scope, delegation rules, collaborative practice agreements, payer enrollment requirements, and billing workflows. Training should be refreshed whenever state law, payer rules, or service lines change.
Telehealth remains a major area of regulatory change as federal and state policymakers continue to evaluate which pandemic-era flexibilities should be extended, modified, or made permanent, including how they interact with the Stark Law, Anti-Kickback provisions. It also prompts considerations of provider incentives, patient access, and enforcement approaches across diverse healthcare markets.
Additionally, coverage and payment rules for telemedicine, remote patient monitoring, remote therapeutic monitoring, behavioral health telehealth, chronic care management, and hybrid care models continue to evolve, along with Medicare telehealth services, Medicaid telehealth coverage, and commercial payer virtual care programs.
Licensure, Prescribing, Consent, Privacy, and Cybersecurity
Telehealth compliance is not limited to reimbursement. Organizations should evaluate licensure, prescribing, informed consent, modality requirements, patient location, provider location, privacy and security, documentation standards, record retention, and fraud and abuse considerations. Cross-state care models, in particular, should be reviewed before expansion.
Telehealth arrangements involving MSOs, professional corporations, leased clinicians, marketing platforms, or referral sources should also be reviewed under AKS, state fee-splitting rules, CPOM doctrines, and payer contract requirements. Administrative fee models, revenue-sharing arrangements, and platform relationships may require particular scrutiny.
Recommended action: Organizations should maintain a telehealth compliance matrix that addresses state licensure, prescribing rules, payer coverage, coding, consent, privacy safeguards, cybersecurity controls, and patient follow-up. Policies should be tested against actual workflows, not merely maintained as standalone documents.
4. Corporate Practice of Medicine, MSO Compliance, Fee-Splitting, and Professional Corporation Governance
Clinical Control and Corporate Practice of Medicine Restrictions
State corporate practice of medicine doctrines and related fee-splitting rules are receiving renewed attention, especially in arrangements involving private equity-backed platforms, MSOs, telehealth companies, professional corporations, friendly physician models, dental service organizations, management services agreements, and multi-state practice models. Regulators are increasingly focused on substance over form: who controls clinical decisions, who controls professional ownership, who sets staffing and compensation expectations, who owns or controls patient records, and whether business personnel influence patient care.
Management Services Organization Agreements and Non-Clinical Functions
Traditional MSO structures remain viable in many jurisdictions when properly designed and operated. However, management agreements should clearly separate clinical and non-clinical functions. Licensed professionals should retain authority over diagnosis, treatment, clinical protocols, supervision, professional judgment, patient records, and quality of care. MSOs should avoid contractual or operational rights that give them de facto control over professional practice decisions.
Recommended action: Multi-state organizations should maintain state-specific CPOM analyses, governance documents, management agreements, fee schedules, clinical-control protocols, and escalation procedures. Particular attention should be paid to stock transfer restrictions, replacement rights, management termination rights, percentage-based fees, non-compete provisions, clinical staffing control, and communications that may suggest non-clinical control over patient care.
5. Ancillary Service Billing Compliance, Medical Necessity, Revenue Cycle, and Payer Audit Risk
Laboratory, Imaging, Therapy, DME, and Remote Monitoring Services
Ancillary service lines—including laboratory testing, imaging, physical therapy, durable medical equipment, remote patient monitoring, remote therapeutic monitoring, in-office ancillary services, diagnostic testing, and specialty ancillary services—remain attractive from an operational and patient-care perspective. They also remain vulnerable to scrutiny when ordering patterns, billing practices, medical necessity documentation, supervision requirements, payer contract obligations, or referral relationships are not well controlled.
Medical Necessity, Coding, Claims Submission, and Audit Controls
Billing compliance should be evaluated alongside fraud and abuse, payer contract, and medical necessity considerations. Common risk areas include insufficient documentation of medical necessity, standing orders that are not individualized, improper use of modifiers, billing for non-covered services, failure to meet supervision requirements, and compensation models that may create referral-related incentives.
Organizations should establish written protocols for ordering, performing, documenting, coding, billing, and auditing ancillary services. Internal audits should be risk-based and should include both claim-level review and operational review of referral flows, provider education, denial trends, refund processes, and corrective action.
Recommended action: Practices should confirm that ancillary services are clinically appropriate, adequately documented, properly ordered, and accurately billed. Where financial relationships exist among ordering providers, ancillary entities, MSOs, laboratories, imaging centers, or therapy providers, organizations should review Stark Law, AKS, state law, and payer contract implications before continuing or expanding the arrangement.
Practical Health Care Compliance Checklist for Physician Practices and Ancillary Services
Inventory physician, provider, MSO, telehealth, marketing, and ancillary service arrangements.
Confirm that each arrangement has a documented business need, fair market value support, and commercial reasonableness analysis where appropriate.
Evaluate arrangements separately under Stark Law, AKS, state self-referral laws, fee-splitting rules, and CPOM doctrines.
Refresh state-specific scope-of-practice, supervision, delegation, and licensure protocols.
Review telehealth workflows for licensure, prescribing, consent, payer coverage, coding, documentation, privacy, and cybersecurity requirements.
Audit ancillary service ordering, documentation, coding, claim submission, denials, refunds, and corrective action processes.
Train clinical, administrative, billing, contracting, and leadership teams on updated policies and escalation procedures.
Maintain board or leadership oversight of high-risk arrangements and document compliance decisions contemporaneously.
Client Compliance Checklist: Stark Law, AKS, Telehealth, MSO, CPOM, Revenue Cycle, and Billing Controls
The following checklist is intended to help health care organizations assess whether current arrangements, policies, and operational workflows are aligned with key fraud and abuse, reimbursement, corporate practice, telehealth, and ancillary service compliance expectations. Organizations should tailor the checklist to their state law requirements, payer contracts, service lines, and risk profile.
Workstream
Client Action Items
Key Documentation
Suggested Owner / Cadence
Governance and Compliance Program
Confirm that compliance oversight is assigned to leadership, a compliance officer, or a compliance committee; conduct periodic risk assessments; maintain escalation procedures for identified issues.
Compliance / Legal; annual risk assessment with quarterly monitoring.
Physician and Provider Financial Relationships
Inventory employment, independent contractor, medical director, call coverage, marketing, lease, and referral-source arrangements; evaluate Stark Law and AKS separately.
Executed agreements, fair market value support, commercial reasonableness memoranda, board approvals, payment records.
Legal / Finance / Compliance; before execution, renewal, amendment, and annually for high-risk arrangements.
Fair Market Value and Commercial Reasonableness
Confirm that compensation is set in advance where required, supported by appropriate valuation materials, and not determined by the volume or value of referrals or other business generated.
FMV opinions, compensation surveys, productivity data, service need analysis, payment methodology records.
Finance / Legal; before execution and when compensation changes.
Scope of Practice and Supervision
Review state-specific rules for physicians, nurse practitioners, physician assistants, pharmacists, behavioral health providers, and other clinicians; confirm supervision, delegation, and billing workflows.
Collaborative agreements, supervision protocols, credentialing files, job descriptions, training materials.
Clinical Leadership / HR / Compliance; at onboarding and when state or payer rules change.
Telehealth and Remote Care
Verify licensure, patient and provider location rules, prescribing requirements, consent, modality requirements, coding, documentation, privacy, cybersecurity, and payer coverage.
Operations / Compliance / IT Security; quarterly for active programs and before expansion into new states.
Corporate Practice of Medicine and MSO Arrangements
Confirm that licensed professionals retain clinical control and that MSO functions remain non-clinical; review fee structures, governance rights, replacement rights, and communications for de facto control concerns.
Legal / Executive Leadership; before launch, transaction, restructuring, or state expansion.
Ancillary Services and Billing Compliance
Review ordering, medical necessity, supervision, documentation, coding, claims submission, denial management, refund processes, and corrective action for lab, imaging, therapy, DME, and remote monitoring services.
Order forms, medical records, billing policies, audit reports, denial logs, refund documentation, corrective action plans.
Revenue Cycle / Compliance / Clinical Operations; routine risk-based audits and targeted reviews after payer inquiries.
Training and Monitoring
Train clinical, billing, contracting, administrative, and leadership teams on current policies; monitor whether arrangements and workflows operate as documented.
Training attendance records, policy attestations, monitoring reports, hotline or reporting logs.
Compliance / HR; at onboarding and annually, with refreshers after material changes.
Clients should consider prioritizing arrangements that involve referral sources, percentage-based compensation, multi-state telehealth operations, non-clinical management control, high-volume ancillary services, or recent payer audit activity. Any identified gaps should be documented, assigned to a responsible owner, and tracked through remediation.
Key Takeaway for Health Care Organizations
Health care organizations should not assume that legacy structures, form agreements, or isolated compliance reviews will be sufficient in the current enforcement environment. Regulators, payers, and transaction counterparties are increasingly examining how arrangements operate in practice. A coordinated review of provider relationships, physician compensation arrangements, MSO structures, telehealth models, digital health platforms, scope-of-practice protocols, ancillary service billing, revenue cycle compliance, payer audit response, and overpayment refund processes can help identify and remediate risk before it becomes a regulatory, reimbursement, enforcement, or transaction issue.
If you have questions about these developments or would like assistance evaluating your organization’s provider arrangements, MSO structure, telehealth model, or ancillary service compliance program, please contact a member of our Health Care Regulatory and Compliance team.
This Alert is intended for general informational purposes only and does not constitute legal advice. Readers should consult legal counsel regarding how the issues discussed may apply to specific facts and circumstances.
False Claims Act Cases (FCA) remain one of the government’s most powerful health care enforcement tools. Recent matters illustrate its broad reach and continuing implications for providers, payors, and suppliers. This client alert highlights notable developments and practical steps organizations can take to mitigate risk.
Over the past year, courts and the Department of Justice (DOJ) have continued to pursue False Claims Act Cases involving improper billing, kickback arrangements, and misrepresentations about services provided. Recent settlements involving hospitals, outpatient providers, and pharmaceutical companies underscore the continuing risk for organizations that seek reimbursement from federal health care programs.
Recent Case False Claims Act Cases Highlights
Kickbacks and Referral Schemes: A major hospital system recently resolved allegations that it provided unlawful financial incentives to physicians in exchange for patient referrals. The alleged arrangements included disguised consulting agreements and excessive compensation for limited services, raising Anti-Kickback Statute concerns. The settlement included a substantial payment and enhanced compliance monitoring.
Billing for Non-Rendered Services: A large outpatient provider allegedly billed for physical therapy sessions that did not occur. Whistleblower reports and internal audits identified falsified patient records and claims for services that were not provided or were performed by unqualified staff. The matter resulted in significant penalties and a corporate integrity agreement.
Pharmaceutical Pricing and Marketing: Recent pharmaceutical FCA matters have targeted alleged inflation of drug prices reported to government programs and promotion of medications for unapproved uses. In one matter, a drug manufacturer allegedly misreported Medicaid rebate data and incentivized sales representatives to promote off-label uses, contributing to a significant settlement.
Legal Trends and Enforcement PrioritiesReflected in False Claims Act Cases
Whistleblower (qui tam) actions remain a key driver of FCA enforcement and a significant source of fraud allegations. Although courts continue to scrutinize whether alleged false claims are material under recent Supreme Court guidance, DOJ enforcement remains active and aggressive.
The FCA’s incentive structure helps explain the continued volume of qui tam activity. Private relators may bring claims on the government’s behalf and, in successful cases, receive a share of the government’s recovery. Relators may also benefit from statutory anti-retaliation protections, while treble damages and civil penalties create substantial settlement pressure for defendants.
Practical Guidance for Health Care Clients
Strengthen compliance policies governing billing, referral relationships, and service documentation.
Train personnel on FCA risks, reporting obligations, and whistleblower protections.
Use periodic audits to identify, investigate, and remediate potential FCA exposure.
Respond promptly to government inquiries and preserve relevant records.
Given the continued pace of FCA enforcement, health care organizations should take a proactive, well-documented approach to compliance. For assistance evaluating FCA risk or strengthening compliance strategies, please contact our health care law team.
Conclusion
Recent FCA activity confirms that health care providers remain a central focus of federal enforcement, particularly where billing practices, referral relationships, documentation, and pharmaceutical reporting are at issue. Organizations that invest in strong compliance controls, timely internal review, and clear reporting channels will be better positioned to identify risk early and respond effectively when concerns arise.
Understanding FCA Risks and How Compliance Can Protect Your Practice
Executive summary: FCA exposure can escalate quickly when billing errors repeat across many claims. Moreover, this alert explains the conduct that can trigger False Claims Act Liability. It also shows how penalties and treble damages compound exposure. Additionally, it outlines why providers should maintain active compliance programs. These programs help identify, correct, and document billing issues before they become systemic.
The federal False Claims Act (FCA) is one of the government’s primary tools for addressing allegedly false or fraudulent claims submitted to federal healthcare programs. Healthcare providers face heightened FCA risk because Medicare and Medicaid billing involves high claim volume, complex coding rules, and evolving reimbursement requirements. For medical practices, understanding how FCA liability arises—and how quickly penalties and damages can escalate—is essential to maintaining effective billing controls and protecting the organization’s financial stability.
FCA Liability: What Triggers It?
Liability under the FCA arises when an individual or entity knowingly submits a false or fraudulent claim for payment. For FCA purposes, ‘knowingly’ includes actual knowledge, deliberate ignorance, or reckless disregard of the claim’s truth. Moreover, proof of specific intent to defraud is not required. Common triggers include incorrect coding, upcoding, unbundling, and billing for services not rendered. Repeated billing errors can create significant exposure. They are especially concerning if they suggest weaknesses in controls. This may indicate a failure to investigate and correct known problems, creating False Claims Act Liability.
To illustrate the magnitude of FCA exposure, consider a hypothetical medical practice that incorrectly billed a particular code five times per day over five years. Assuming 260 working days per year, this results in 5 claims x 260 days x 5 years = 6,500 potentially false claims submitted.
Under the FCA, each false claim may carry a statutory civil penalty in addition to treble damages. Using 2026 penalty figures for this illustration, the total minimum penalty would be 6,500 claims x $13,946 = $90,649,000. The total maximum penalty would be 6,500 claims x $27,894 = $181,311,000. These figures are separate from any damages based on the alleged overpayment, which may be trebled under the FCA.
Assuming each of these 6,500 false claims was for $100, the total overpayment would be 6,500 x $100 = $650,000. If trebled, that amount would rise to $1,950,000. Adding the 2026 statutory penalties described above produces a total illustrative liability range of $92,599,000 to $183,261,000, before considering any other costs, collateral consequences, or settlement factors.
Therefore, the total illustrative liability would consist of trebled damages plus statutory penalties. Using the assumptions above, minimum liability would be $1,950,000 in trebled damages plus $90,649,000 in minimum penalties, yielding $92,599,000. Maximum liability would be $1,950,000 plus $181,311,000 in maximum penalties, yielding $183,261,000. This example demonstrates how even a modest per-claim overpayment can become an existential financial threat under the FCA, further underscoring the need for rigorous compliance protocols.
Item
Calculation
Minimum Amount
Maximum Amount
Total False Claims
5 claims/day x 260 days/year x 5 years
6,500 claims
6,500 claims
Statutory Civil Penalty (2026 figures)
6,500 claims x [penalty per claim]
$90,649,000 (6,500 x $13,946)
$181,311,000 (6,500 x $27,894)
Total Overpayment
6,500 claims x $100
$650,000
$650,000
Trebled Damages
$650,000 x 3
$1,950,000
$1,950,000
Total Liability
Statutory Civil Penalty + Trebled Damages
$90,649,000 + $1,950,000 = $92,599,000
$181,311,000 + $1,950,000 = $183,261,000
Astronomical Damages: Financial Risks and Impact
Additionally, potential damages under False Claims Act Liability can be astronomical. They threaten the financial viability of even well-established practices. Providers found liable may face monetary penalties as well as reputational harm and federal program exclusion.
The Importance of Compliance Programs
Ongoing compliance programs are a critical tool for reducing FCA risk. By establishing robust policies, conducting regular training, and performing periodic audits, practices can detect and correct billing errors before they become systemic. Compliance programs encourage a culture of accountability and transparency, helping staff understand legal requirements and billing expectations. A well-documented compliance program may also support mitigation arguments if issues arise, although it does not eliminate liability for false claims.
Compliance programs also provide guidance on evolving regulations, helping providers adapt to changes in billing standards and maintain ethical practices. Investing in compliance is not just a legal necessity; it is a strategic safeguard that protects the practice’s finances, reputation, and continued ability to serve patients.
Conclusion: Key Takeaways and Recommendations
False Claims Act Liability poses significant risks for healthcare providers.
This can trigger substantial damages from repeated billing errors, even with small amounts.
Additionally, the best risk-management approach is a strong, ongoing compliance program that promotes accuracy, accountability, and ethical conduct.
Healthcare providers should regularly review billing practices and audit high-risk codes.
They should train staff on coding and documentation; document corrective actions, and consult counsel when issues arise.
Proactive measures today can help prevent costly disputes tomorrow.
Substance Abuse Treatment Center Fraud Scheme Results in Guilty Plea
The Department of Justice recently announced the guilty plea of two individual alcohol and substance abuse treatment center owners for their participation in what DOJ labeled a “multi-million dollar health care fraud and money laundering scheme.” The two individuals owned a licensed substance abuse service provider (or treatment center) offering clinical treatment services for persons suffering from alcohol and drug addiction. The treatment center also offered medication-based treatment for opioid addiction.
The government had accused the two owners of paying illegal kickbacks/bribes to “sober homes” in exchange for the referral of the sober homes’ insured residents to treatment program. The sober homes provided safe and drug-free residences for individuals suffering from drug and alcohol addiction. This made them a prime source of potential referrals to the treatment program.
The accusations against these defendants read like a laundry list of thinly veiled kickback schemes. Some of the specific accusations included:
Providing funds used to purchase or rent several sober home properties under purchase agreements or leases that were in the names of other parties so as to disguise the source of funds.
Paying remuneration for referrals in the form of free or reduced rent, insurance premium payments, and other benefits to individuals with insurance who agreed to reside at the sober homes and attend drug treatment.
Using a separate entity to pay insurance premiums for treatment patients so that the treatment program could continue to bill the patients’ insurance companies for treatment expenses.
Hiring a doctor to serve as the medical director who frequently pre-signed prescriptions that were used to dispense controlled substances.
Continuing to employ the medical director after the doctor’s license was suspended.
Failing to inform the Florida Department of Children and Families that it could not continue to operate when the treatment center lost the medical director.
Submitting insurance claims that falsely stated that testing and treatment was medically necessary.
If the allegations made by the government are to be believed, the treatment center is an illustration of exactly what intentional fraud looks like. This was not a mistake. Rather, it appears that the defendants deliberately set up a system intended to generate referrals and providing financial benefits to individuals in a position to make or influence those referrals. In short, this is what health care fraud looks like.
Providers that we deal with go to great lengths just to make certain that they proactively look for potential risk areas and take affirmative and proactive actions to be certain that they are not making mistakes that could inadvertently result in an overpayment or imputed knowledge. A great deal of expense goes into assuring that these providers are in complete compliance. By contrast, cases like the one involving these treatment programs illustrate the very reason why well providers with the best of intentions find it necessary to look over their shoulders.
An $18 million settlement was agreed by a hospital chain after allegations that claims were submitted to Medicare for patients who were admitted to an inpatient facility when they allegedly could have been treated on a less costly outpatient basis. The government alleged that the hospital system billed Medicare for short-stay, inpatient procedures that should have been billed on a less costly outpatient basis. The government also accused the hospital system of inflating reports to Medicare regarding the number of hours of outpatient observation care that was provided.
This is a fairly typical case where the allegation involved billing for services that were of a higher level than required by the patient. In effect, the excess services are deemed to be medically unnecessary. In this case, the services involved inpatient admissions that the government alleged could have been taken care of in a less costly outpatient setting.
A former employee was the whistleblower in the case and walks away with over $3.25 million from the settlement.
If you navigate to the American Hospital Association (AHA) Interactive Town Hall of January 17, 2018, you can view a video in which Seema Verma, the current Administrator of the Centers for Medicare and Medicaid Services, discusses some of the efforts currently underway at CMS to ease the burden of applicable regulations through the Medicare and Medicaid programs. The interactive Town Hall opens with a statement from the current president of the AHA, Richard J. Pollock, in which he discusses the overwhelming burden hospitals face to comply with the voluminous regulations that apply to their operations. During Mr. Pollock’s presentation, you cannot help thinking, “dude, she is sitting right there.” Mr Pollock lambasts the massive regulatory burden imposed on hospitals. About half way through his introduction, you begin to realize there must be something big coming.
Mr. Pollock’s presentation is a perfect setup for Administrator Verma who begins her presentation, and after a few opening remarks, announces that CMS is establishing an inter-agency group that will review the existing Stark Law. Anyone who works in the health care industry will have heard of the Stark Law. The law generally prohibits physicians from making referrals for certain services, known as “designated health services,” to any entity in which the physician or certain designated family members have a prohibited ownership or other financial relationship. The Stark Law is draconian in situations where it applies. Not only is the physician referral prohibited, but the designated health services flowing from the prohibited referral cannot be billed to the Medicare program. Billing and receipt of prohibited reimbursement results in an overpayment which, if not promptly repaid, ripens into a violation of the False Claims Act (FCA). This is where things get dicey because the FCA imposed triple damages, plus $11,000 to $22,000 per claim. These damages add up very, very quickly.
The Stark Law is a strict liability statute. There is no wiggle room. If an improper referral occurs, the statute is violated. Period. This makes the various exceptions that apply to permit certain strictly interpreted arrangements very important and the subject of much scrutiny and analysis. One of the problems is Stark Law regulations are oftentimes unclear in application. Adding to the confusion, CMS has been inconsistent in comments it has issued when adopting and amending various regulations. This leaves us with a law that creates very substantial penalties often very difficult to interpret. The obvious cases are relatively clear. It is on the marginal arrangements the Stark law is difficult to apply. The ambiguity of some of the Stark Law provisions has given many compliance officers and health care attorneys many sleepless nights.
So, now, CMS is setting up this inter-agency group to review the Stark Law as part of its “Patients Over Paperwork” initiative. What the outcome of this effort will be is anyone’s guess. We have the agencies responsible for enforcement conducting the review. It is fairly well publicized these agencies have an 800% return on every dollar they spend on health care fraud and abuse enforcement. Admittedly, the stated purpose of the “Patients Over Paperwork” initiative is to reduce burdensome regulations. This is in alignment with President Trump’s stated objectives of decreasing regulations on businesses.
Even so, it is difficult to see significant revisions coming that will open the door to potential abusive arrangements originally served as the impetus for enacting the Stark Law. It is also difficult to envision federal enforcement agencies voluntarily relinquishing some of the provisions and interpretations of the Stark Law that provide them with teeth in their enforcement efforts. That being said, one area we might see some regulatory reform involves the interplay between the Stark Law and new value-based reimbursement that is being transitioned into the Medicare program. Congress has already held a hearing on how the Stark Law may impede the ability to align the interests of various components of the health care system. It is this type of alignment that is contemplated and, in fact needed, to make cost savings gains under the new value-based reimbursement structures. This area is essentially hanging ripe on the vine for change. Still, significant issues remain as to whether this new CMS inter-agency group has the authority to harmonize Stark Law and value-based reimbursement. Some of the relevant issues cut to the core of the original Stark Law and might not be able to be solved by regulatory actions alone. If congressional action is required, all bets are off and the glimpse of potential relief that is represented by the AHA Town Hall meeting of January 17, 2018, might be fleeting at best.